Evidence map›Paper›PMID 27553805›Full record

ArticleSurgical endoscopy2017

Barrett's esophagus after Roux-en-Y gastric bypass: does regression occur?

Verónica Gorodner, Rudolf Buxhoeveden, Gastón Clemente, Christian Sánchez, Luis Caro, Alejandro Grigaites

Abstract read
PubMed Publisher
In one paragraph

Article in Surgical endoscopy, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed, 2 pooled it
4.4field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 2 syntheses or guidelines pooled it, 39 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Review
  5. Treatment of esophageal adenocarcinoma in patients with a history of bariatric surgery.Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract · 2024
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Pyloroplasty and the risk of Barrett's esophagus in patients with gastroparesis.Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus · 2020
    Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Review
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Verónica GorodnerPrograma de Unidades Bariátricas, Buenos Aires, Argentina. vgorodner_72@yahoo.com.ar.ORCID 0000-0002-0023-2114
Rudolf BuxhoevedenPrograma de Unidades Bariátricas, Buenos Aires, Argentina.
Gastón ClementePrograma de Unidades Bariátricas, Buenos Aires, Argentina.
Christian SánchezGEDYT Gastroenterología Diagnóstica y Terapéutica, Buenos Aires, Argentina.
Luis CaroGEDYT Gastroenterología Diagnóstica y Terapéutica, Buenos Aires, Argentina.
Alejandro GrigaitesPrograma de Unidades Bariátricas, Buenos Aires, Argentina.
Gastroenterología Diagnóstica Terapeútica · ARFundación Ciencias Exactas y Naturales · AR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionBarrett's esophagus (BE) is recognized as a premalignant lesion for esophageal adenocarcinoma. BE appears as a consequence of gastroesophageal reflux disease (GERD), which is increased among obese population. Laparoscopic Roux-en-Y gastric bypass (LRYGB) is the best treatment option for obesity combined with GERD. However, data on evolution of BE after LRYGB are scarce. METHODS AND PROCEDURES: Patients were studied with esophagogastroduodenoscopy (EGD) and gastric biopsy preoperatively. If BE was suspected, esophageal biopsy was performed. If BE was confirmed, LRYGB was indicated with yearly surveillance EGD with biopsies. LRYGB patients who had BE with at least 1-year follow-up were included.

resultsBetween 10/07 and 1/16, 2144 patients underwent laparoscopic bariatric surgery at our institution. There were 1681 (78 %) LRYGB, 399 (19 %) laparoscopic sleeve gastrectomies, and 64 (3 %) revisions. Nineteen patients (0.9 %) had BE preoperatively, and they all underwent LRYGB; 11 of them (58 %) were eligible for this study. There were 6 women and 5 men, mean age 49 ± 11 years, initial BMI 44 ± 6 kg/m

conclusionOur preliminary data showed that LRYGB is a suitable treatment option for obese patients with BE, demonstrated by 36 % regression rate of this premalignant disease. Although BE persisted in the remaining patients, no progression to dysplasia was observed. A larger number of patients and longer follow-up are needed for more definitive conclusions.

Indexed as

Gastric BypassLaparoscopyAdultBarrett EsophagusBiopsyEndoscopy, Digestive SystemEsophagusFemaleFollow-Up StudiesHumansMaleMiddle AgedObesityRetrospective StudiesTreatment OutcomeBarrett’s esophagusGastroesophageal reflux diseaseObesityRoux-en-Y gastric bypass

Identifiers

PMID27553805
OpenAlexW2517704126

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.